Sirolimus is indicated for the prevention of organ transplant rejection and for the treatment of lymphangioleiomyomatosis (LAM). Sirolimus (Fyarro), as protein-bound particles, is indicated for the treatment of adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).<\/p>\n
Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumor (PEComa). It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants. It is a mechanistic target of rapamycin kinase (mTOR) inhibitor that inhibits activation of T cells and B cells by reducing their sensitivity to interleukin-2 (IL-2). It was approved by the U.S. Food and Drug Administration (FDA) in September 1999.<\/p>\n
If sirolimus protein-bound are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 2021<\/p>\n","protected":false},"excerpt":{"rendered":"
Fyarro (sirolimus protein-bound particles) (albumin-bound) is a prescription medicine used for advanced malignant perivascular epithelioid cell tumor (PEComa) in adults.<\/p>\n
DISEASE INDICATIONS-Soft Tissue Sarcoma
\nMANUFACTURER-Aadi Bioscience
\nUSAGE-For injectable suspension: lyophilized powder containing 100 mg of\u00a0sirolimus formulated as albumin-bound particles in single-dose vial\u00a0for reconstitution.
\nMEDICINE APPROVED BY-Food and Drug Administration (FDA)<\/p>\n
Summary of FDA-approved use on approval date: Click Here<\/a> If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201calbumin-bound-injection\u201d based on the information you provide.<\/p>\n
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n